ScreenerHero

BGD Biogened S.A.

GPW · PL · Healthcare · Drug Manufacturers - Specialty & Generic · biogened.pl
18.90PLN-4.55%Mkt Cap: 11.76M $P/E: 9.64

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand, as well as thermal water. It also exports its products. The company was incorporated in 20…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap11.76M USD
Enterprise Value17.06M USD
Revenue (TTM)27.89M USD
Gross Profit18.26M USD
Net Income (TTM)1.25M USD
Revenue/Share44.83 PLN
Last Price18.90 PLN
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees186
CountryPL
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)9.64
P/E (Forward)—
PEG—
EV/EBITDA5.20
EV/Revenue0.61
P/S0.44
P/B1.02
EPS (TTM)1.96
EPS (Forward)—
52W Range
17.3019% of range25.60
52W High25.60 PLN
52W Low17.30 PLN
Profitability
Gross Margin63.75%
Oper. Margin8.16%
EBITDA Margin11.78%
Profit Margin4.37%
ROE10.98%
ROA5.67%
Growth
Revenue Growth5.30%
Earnings Growth-4.30%
Cash Flow & Leverage
Operating CF3.16M USD
CapEx (TTM)1.86M USD
FCF Margin6.83%
FCF Yield16.20%
Net Debt4.75M USD
Net Debt/EBITDA1.45
Balance Sheet
Debt/Equity0.51
Current Ratio2.50
Quick Ratio1.32
Book Value/Sh19.43 PLN
Cash/Share4.19 PLN
Dividends
Fwd Div Rate0.50 PLN
Trail. Div Rate0.00 PLN
Div. Yield2.54%
5Y Avg Yield2.02%
Payout Ratio23.96%
Ex-Div DateSep 10, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.46M
Float144.73K
Insiders94.11%
Institutions0.00%
Technical
SMA 5019.82 (-4.7%)
SMA 20019.58 (-3.5%)
Beta-0.01
S&P 52W Chg16.45%
Avg Vol (30d)59
Avg Vol (10d)5
Technical Indicators
RSI (14)38.8
MACD-0.0663
MACD Signal0.0941
MACD Hist.-0.1604
BB Upper21.93 PLN
BB Middle20.22 PLN
BB Lower18.51 PLN
BB Width16.92%
ATR (14)0.6596 PLN
Vol Ratio (20d)0.99x